🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The purpose of this study is to assess the safety and efficacy of tenofovir...
Status
Completed
Location
Faculdade de Medicina - UFMG
Start Date
2006-06
Trial ID
NCT00352053
Treatments Being Tested
The purpose of this study is to show if a dose of T-20 added to an anti-HIV...
Status
Completed
Location
Carlton Clinic
Start Date
TBD
Trial ID
NCT00021554
Treatments Being Tested
Vicriviroc (vye-kri-VYE-rock) is an investigational drug (not yet approved ...
Status
Completed
Location
Multiple Locations
Start Date
2008-03
Trial ID
NCT00632073
Treatments Being Tested
This is a Phase 2b/3, multi-center, two part study, designed to evaluate th...
Status
Completed
Location
CD02 Investigational site
Start Date
2015-10
Trial ID
NCT02483078
Treatments Being Tested
The purpose of this study is to compare the change in viral load (amount of...
Status
Completed
Location
Univ of Alabama at Birmingham
Start Date
TBD
Trial ID
NCT00008528
Treatments Being Tested
The investigational product, ibalizumab, is a humanized IgG4 monoclonal ant...
Status
Completed
Location
AIDS Health Care Foundation - Research
Start Date
2008-08
Trial ID
NCT00784147
Treatments Being Tested
This protocol serves to extend the successful treatment for HIV positive pa...
Status
Completed
Location
Kaiser Permanente Southern California
Start Date
2009-11
Trial ID
NCT01056393
Treatments Being Tested
This Phase I/II study evaluated the pharmacokinetics, safety, and tolerabil...
Status
Completed
Location
Byramjee Jeejeebhoy Medical College (BJMC) CRS
Start Date
2019-02-18
Trial ID
NCT03141060
Treatments Being Tested
The goal of this clinical study is to learn more about the study drug, lena...
Status
Recruiting
Location
Grady Health System, Ponce De Leon Center
Start Date
2025-03-26
Trial ID
NCT06749054
Treatments Being Tested